RxISK

Making Medicines Safer for All of Us

Drug Search by Year (Detail)

Side effect search by year (detail)

Drug:

Reaction: VISUAL IMPAIRMENT

20260101 - 20261231

No. 1 - 100

Next page: 2 next page>>
No.
safetyreportid
occurcountry
patientonsetage
patientsex 1:M 2:F
Adverse reaction
Drug (openfda.generic_name, medicinalproduct)
1
26555312
US
 2
Myocardial infarction, Diabetes mellitus, Blood glucose increased, Nasopharyngitis, Throat irritation, Cough, Headache, Visual impairment,
INCLISIRAN,
2
26555426
CA
 56 2
Myasthenia gravis, Myasthenia gravis, Nausea, Frustration tolerance decreased, Pain in extremity, Feeling hot, Visual impairment, Fatigue,
HUMAN IMMUNOGLOBULIN G, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, PYRIDOSTIGMINE BROMIDE,
3
26555438
US
 44 1
Cataract, Visual impairment,
RISANKIZUMAB-RZAA,
4
26555452
US
 73 2
Surgery, Joint dislocation, Autoimmune disorder, Eye inflammation, Stenosis, Visual impairment, Erythema, Fall, Vision blurred, Skin exfoliation, Stress,
ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, INDAPAMIDE, MOMETASONE, ROSUVASTATIN, DICLOFENAC, DICLOFENAC SODIUM,
5
26555463
US
 2
Eyelid discolouration, Visual impairment, Product substitution issue,
LATANOPROST,
6
26555587
US
Visual impairment, Headache,
PRABOTULINUM TOXIN TYPE A,
7
26555965
US
 63 1
Incorrect dose administered, Visual impairment,
TIRZEPATIDE,
8
26556146
US
 69
Cataract operation, Visual impairment, Vitreous floaters, Eczema, Off label use,
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, HYALURONIC ACID,
9
26556654
US
Eyelid ptosis, Visual impairment, Drug effect less than expected, Off label use,
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A,
10
26556754
US
 2
Macular degeneration, Visual impairment,
DUPILUMAB,
11
26557158
CA
 60 1
Neuropathy peripheral, Cough, Dyspnoea, Asthma, Full blood count abnormal, Visual impairment, Paraesthesia, Eosinophil count increased, Product use in unapproved indication, Productive cough, Malaise, Gastrooesophageal reflux disease, Hypoaesthesia, Disease recurrence, Therapeutic product effect incomplete, Haemoptysis, Eosinophilic granulomatosis with polyangiitis, Upper respiratory tract infection, Drug dependence, Vasculitis,
FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, BUDESONIDE, BUDESONIDE, BUDESONIDE, RANIBIZUMAB, MOMETASONE, MOMETASONE FUROATE, MOMETASONE, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, GLYCOPYRROLATE, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG,
12
26557400
US
 2
Visual impairment, Product storage error, Wrong technique in device usage process,
ALIROCUMAB,
13
26557441
US
 69 2
Arthralgia, Vision blurred, Asthma, Product dose omission issue, Visual impairment,
DUPILUMAB,
14
26557574
US
 72 1
Visual impairment,
INSULIN GLARGINE,
15
26557619
US
 44 1
Lacrimation increased, Visual impairment, Product use in unapproved indication,
DUPILUMAB, DUPILUMAB,
16
26558723
EU
 64 2
Corneal epitheliopathy, Corneal epithelium defect, Punctate keratitis, Visual acuity reduced, Blepharitis, Corneal epitheliopathy, Corneal opacity, Visual impairment, Photophobia,
MIRVETUXIMAB SORAVTANSINE, MIRVETUXIMAB SORAVTANSINE, MIRVETUXIMAB SORAVTANSINE, MIRVETUXIMAB SORAVTANSINE, MIRVETUXIMAB SORAVTANSINE,
17
26558760
US
 1
Visual impairment, Blood glucose abnormal, Loss of therapeutic response,
SUVOREXANT, SUVOREXANT, SUVOREXANT,
18
26559221
AU
 1
Retinopathy, Viral infection, Anxiety, Insomnia, Burnout syndrome, Fear of disease, Social avoidant behaviour, Disturbance in attention, Visual impairment,
INSULIN ASPART INJECTION, INSULIN ASPART, INSULIN LISPRO, INSULIN GLARGINE-YFGN, INSULIN GLARGINE,
19
26559899
Visual impairment,
LORATADINE, LORATADINE TABLET,
20
26560299
US
 47 1
Neutropenia, Photophobia, Visual impairment, Ocular hyperaemia, Eye swelling, Periorbital swelling,
NIVOLUMAB, DACARBAZINE, DOXORUBICIN, IVERMECTIN, MEBENDAZOLE, VITAMIN C,
21
26560593
US
 2
Meningioma, Intraosseous meningioma, Visual impairment,
MEDROXYPROGESTERONE ACETATE,
22
26560613
US
 49 2
Anger, Visual impairment, Tachyphrenia, Fall,
NATALIZUMAB, NATALIZUMAB,
23
26560802
US
Visual impairment,
TIRZEPATIDE,
24
26560923
US
 2
Visual impairment, Eyelid discolouration,
LATANOPROST,
25
26560925
EU
 86 2
Asthenia, Neutropenia, Platelet count decreased, Bacterial diarrhoea, Cataract, Corneal epithelial microcysts, Visual impairment, Back pain, Fatigue, Dizziness, Diarrhoea infectious,
POMALIDOMIDE, BELANTAMAB MAFODOTIN,
26
26560936
US
 1
IVth nerve paralysis, Visual impairment,
SEMAGLUTIDE, ORAL SEMAGLUTIDE,
27
26560956
US
Gait disturbance, Chest discomfort, Weight increased, Chest pain, Visual impairment, Oedema, Disorientation, Dyspnoea, Constipation, Prescribed underdose, Dizziness,
SPARSENTAN, BUDESONIDE, EVOLOCUMAB, OMEPRAZOLE MAGNESIUM, EMPAGLIFLOZIN, SODIUM ZIRCONIUM CYCLOSILICATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, LOSARTAN, METOPROLOL TARTRATE, METOPROLOL, ALLOPURINOL, ALBUTEROL SULFATE, ALBUTEROL, NITROGLYCERIN,
28
26561325
EU
 56 2
Angiopathy, Gastrointestinal sounds abnormal, Increased appetite, Visual impairment, Eructation, Flatulence, Diarrhoea, Product use issue, Drug titration error,
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, CANDESARTAN, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, BISOPROLOL FUMARATE, AMLODIPINE BESYLATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE,
29
26550002
US
 87 2
Oedema peripheral, Movement disorder, Freezing phenomenon, Medical device site pain, Fall, Pain, Drug ineffective, Gait disturbance, Pain in extremity, Visual impairment,
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA,
30
26550024
US
 1
Visual impairment,
DUPILUMAB, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN,
31
26550044
US
 1
Dry eye, Sleep disorder due to a general medical condition, Visual impairment, Skin ulcer, Dry skin,
DUPILUMAB, TRALOKINUMAB-LDRM, NEMOLIZUMAB-ILTO, FEXOFENADINE HYDROCHLORIDE, LISINOPRIL, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OXYMETAZOLINE HYDROCHLORIDE, OXYMETAZOLINE HYDROCHLORIDE., TESTOSTERONE CYPIONATE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, CETIRIZINE HYDROCHLORIDE,
32
26550889
EU
 59 2
Visual impairment, Flushing, Nausea, Heart rate increased, Dyspnoea, Hypotension,
PEMBROLIZUMAB, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS,
33
26551220
US
 41 1
Visual impairment, Vitreous floaters, Eye pain, Colour blindness, Feeling abnormal, Insomnia, Confusional state, Photophobia,
SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER,
34
26551242
US
 76 2
Cataract, Visual impairment, Injection site pain, Dry eye, Therapeutic product effect incomplete,
DUPILUMAB,
35
26551285
US
 86 1
Blindness, Visual impairment, Erythema, Skin exfoliation, Rash,
DUPILUMAB, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%,
36
26551450
US
 80 1
Visual impairment, Product taste abnormal, Incorrect dose administered, Device issue, Product dose omission issue,
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE,
37
26551476
US
 76 1
Visual impairment, Psoriasis,
RISANKIZUMAB-RZAA,
38
26551597
US
 50 1
Eye pain, Visual impairment, Cataract, Erythema of eyelid, Blepharitis, Product dose omission issue, Eye discharge, Lacrimation increased, Product administration error, Eye operation,
CENEGERMIN-BKBJ, CENEGERMIN-BKBJ, VITAMIN A, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, DEXTROMETHORPHAN HYDROBROMIDE, BUPROPION HYDROCHLORIDE, BUPROPION, ESCITALOPRAM, VALACYCLOVIR HYDROCHLORIDE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, MOXIFLOXACIN, MOXIFLOXACIN HYDROCHLORIDE, PREDNISOLONE ACETATE, ALLANTOIN, BACITRACIN AND POLYMYXIN B SULFATE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, BUPROPION HYDROCHLORIDE,
39
26551693
US
 75 2
Glaucoma, Visual impairment,
ETANERCEPT,
40
26551847
US
 1
Diabetes mellitus, Visual impairment,
SODIUM ZIRCONIUM CYCLOSILICATE, DAPAGLIFLOZIN,
41
26552323
US
 74 2
Visual impairment,
INSULIN LISPRO, INSULIN GLARGINE, INSULIN GLARGINE,
42
26552433
EU
 2
Weight increased, Insulin resistance, Food craving, Lack of satiety, Impaired driving ability, Visual impairment, Alopecia, Memory impairment, Fatigue, Somnolence, Irritability, Therapeutic response unexpected, Product availability issue, Intentional dose omission,
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, QUETIAPINE, LORATADINE, LORATADINE ORAL,
43
26552514
GB
 81 1
Diastolic hypertension, Visual impairment, Hypertension, Neurological examination abnormal, Sensory disturbance, Erythema,
VIBEGRON, OXYBUTYNIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, PHENYTOIN SODIUM, RAMIPRIL, TAMSULOSIN HYDROCHLORIDE,
44
26553138
EU
 52 2
Age-related macular degeneration, Eye swelling, Eye pruritus, Visual impairment, Eye pain, Metamorphopsia, Ocular hyperaemia,
45
26553267
US
 5
Visual impairment,
VIGABATRIN, ALBUTEROL SULFATE,
46
26553464
US
 2
Meningioma, Anxiety, Depression, Visual impairment, Amnesia,
MEDROXYPROGESTERONE ACETATE,
47
26553574
US
 76 1
Visual impairment,
INSULIN LISPRO,
48
26553938
US
 2
Visual impairment, Pseudophakia, Cataract, Presbyopia, Retinal haemorrhage,
FARICIMAB, FARICIMAB, FARICIMAB, FARICIMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CARVEDILOL, FUROSEMIDE, GABAPENTIN, HYDRALAZINE HYDROCHLORIDE, LETROZOLE, LETROZOLE TABLETS, NIFEDIPINE, EVOLOCUMAB, CLOPIDOGREL,
49
26554000
US
 29 2
Central vision loss, Eye oedema, Eye pain, Acute macular neuroretinopathy, Eye haemorrhage, Visual impairment, Blindness,
NORGESTIMATE AND ETHINYL ESTRADIOL,
50
26554083
US
 2
Visual impairment,
ENSIFENTRINE,
51
26554273
JP
 84 1
Dyspnoea, Diarrhoea, Pruritus, Condition aggravated, Peripheral coldness, Peripheral coldness, Abdominal distension, Chest discomfort, Decreased appetite, Feeding disorder, Abdominal pain upper, Taste disorder, Decreased appetite, Visual impairment, Dizziness, Nausea, Ligament sprain, Fall, Arthralgia, Bedridden, Dyspnoea, Dry skin, Vision blurred,
NINTEDANIB, NINTEDANIB,
52
26554451
US
 61 1
Scoliosis, Loss of consciousness, Visual impairment, Eye pain, Overdose, Inappropriate schedule of product administration, Weight increased, Procedural pain, Injection site erythema, Injection site bruising,
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE,
53
26554702
EU
 74 2
Speech disorder, White matter lesion, Muscular weakness, Cerebral atrophy, Headache, Nausea, Migraine, Photophobia, Gait disturbance, Paraesthesia, Visual impairment, Migraine with aura, Hemiplegic migraine,
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LETROZOLE, LETROZOLE TABLETS, LETROZOLE, LETROZOLE TABLETS, LETROZOLE, LETROZOLE TABLETS, LETROZOLE, LETROZOLE TABLETS,
54
26555212
US
 75 2
Visual impairment,
MAVACAMTEN,
55
26565271
53 1
Muscular weakness, Adverse reaction, Visual impairment,
PEMBROLIZUMAB, LENVATINIB,
56
26549105
EU
 2
Ophthalmoplegia, Influenza, Visual impairment, Off label use,
BOTULINUM TOXIN TYPE A, BOTULINUM TOXIN TYPE A,
57
26549387
US
 66 2
Visual impairment,
DUPILUMAB,
58
26549546
US
 50 2
Skin exfoliation, Sensitive skin, Dry eye, Visual impairment, Incorrect dose administered,
DUPILUMAB,
59
26549667
US
 49 2
Visual impairment,
DUPILUMAB,
60
26549729
US
 12 2
Visual impairment,
DUPILUMAB,
61
26546791
US
 73 2
Retinitis pigmentosa, Illness, False negative investigation result, Visual impairment,
CLONAZEPAM, CLONAZEPAM,
62
26547092
41
Visual impairment, Device issue,
ZILUCOPLAN, ECULIZUMAB, PREDNISONE, PYRIDOSTIGMINE BROMIDE, HYDROXYZINE, ERGOCALCIFEROL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, DOXYCYCLINE, DOXYCYCLINE HYCLATE, HYDROCHLOROTHIAZIDE, FERROUS SULFATE, METRONIDAZOLE, METRONIDAZOLE TOPICAL, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, ROSUVASTATIN, SITAGLIPTIN, INSULIN GLARGINE, LOSARTAN, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, AMOXICILLIN AND CLAVULANATE POTASSIUM, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM,
63
26547404
US
 70 2
Eye disorder, Visual impairment,
DUPILUMAB,
64
26547629
US
Visual impairment,
OLOPATADINE HYDROCHLORIDE,
65
26547778
US
 59 2
Drug hypersensitivity, Visual impairment, Vision blurred, Periorbital swelling, Eye irritation,
OLOPATADINE HYDROCHLORIDE,
66
26547779
US
Visual impairment, Product use complaint,
OLOPATADINE HYDROCHLORIDE,
67
26547956
US
Visual impairment, Vision blurred,
OLOPATADINE HYDROCHLORIDE,
68
26547987
US
 2
Visual impairment,
INSULIN GLARGINE,
69
26548087
US
 2
Ocular stroke, Product container issue, Visual impairment,
CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN,
70
26548225
CA
 2
Visual impairment, Dizziness, Ear congestion, Influenza, Nasopharyngitis, Vertigo, Asthenia,
ADALIMUMAB-RYVK,
71
26548363
US
 1
Visual impairment,
INSULIN GLARGINE,
72
26548633
US
 60 2
Visual impairment,
INSULIN GLARGINE,
73
26548794
US
 77 1
Salivary hypersecretion, Decreased appetite, Weight decreased, Rash, Dizziness, Nausea, Vomiting, Lacrimation increased, Visual impairment, Gastritis, Abdominal pain upper,
DUPILUMAB, DUPILUMAB, DOXYCYCLINE, DOXYCYCLINE HYCLATE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, PAROXETINE, PAROXETINE HYDROCHLORIDE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE,
74
26541990
EU
 74 2
Cerebral atrophy, Speech disorder, White matter lesion, Muscular weakness, Photophobia, Gait disturbance, Paraesthesia, Visual impairment, Migraine with aura, Hemiplegic migraine, Migraine, Headache, Nausea,
LETROZOLE, LETROZOLE TABLETS, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG,
75
26542393
EU
 67 1
Palpitations, Constipation, Vertigo, Insomnia, Visual impairment, Dyspepsia,
BISOPROLOL FUMARATE,
76
26542735
EU
 62 2
Cerebral atrophy, Empty sella syndrome, Hormone level abnormal, Body temperature decreased, Visual impairment, Tri-iodothyronine decreased, Thyroxine decreased, Blood thyroid stimulating hormone decreased,
LEVOTHYROXINE SODIUM, LIOTHYRONINE SODIUM,
77
26542937
US
 37 2
Cerebrovascular accident, Visual impairment,
DIMETHYL FUMARATE,
78
26543509
US
 49 2
Constipation, Alopecia, Visual impairment, Gastrointestinal pain, Abdominal rigidity, Vitreous floaters,
UPADACITINIB,
79
26544124
GB
Thermal burns of eye, Eye swelling, Ocular hyperaemia, Eye pain, Visual impairment, Dyschromatopsia,
METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM,
80
26544256
EU
 82 2
Visual impairment, Fungal infection,
VORICONAZOLE, VORICONAZOLE INJECTION, AZACITIDINE, AZACITIDINE FOR, HYDROXYUREA,
81
26544344
US
 2
Dyspnoea, Oral candidiasis, Visual impairment, Device issue,
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE,
82
26544464
ZA
 49 2
Retinal thickening, Off label use, Optical coherence tomography abnormal, Visual impairment,
FARICIMAB,
83
26544530
ZA
 2
Optical coherence tomography abnormal, Visual impairment, Retinal thickening,
FARICIMAB, FARICIMAB,
84
26544538
ZA
 52 1
Retinal thickening, Optical coherence tomography abnormal, Visual impairment, Off label use,
FARICIMAB, FARICIMAB, FARICIMAB, BEVACIZUMAB, AFLIBERCEPT,
85
26544633
ZA
 43 2
Dizziness, Insomnia, Nausea, Chills, Visual impairment,
OCRELIZUMAB,
86
26544809
CN
 66 1
Cataract operation, Cardiac disorder, Visual impairment, Hypertension, Nephropathy, Protein urine,
SEMAGLUTIDE,
87
26545150
EU
 83 2
Blepharitis, Hordeolum, Bone pain, Peripheral swelling, Joint swelling, Rash papular, Haematoma, Peripheral venous disease, Lacrimation increased, Corneal epithelial microcysts, Vision blurred, Visual impairment, Arthralgia, Pain in extremity, Post procedural inflammation,
BORTEZOMIB, BELANTAMAB MAFODOTIN,
88
26545222
US
 76 2
Visual impairment,
INSULIN HUMAN, INSULIN HUMAN,
89
26545595
US
 2
Cataract, Visual impairment,
90
26545814
53 2
Dysgeusia, Electric shock sensation, Pain in extremity, Nausea, Chills, Diarrhoea, Back pain, Muscle tightness, Muscle spasms, Muscular weakness, Paraesthesia, Brain fog, Vitreous floaters, Dry eye, Eye irritation, Arthralgia, Abdominal pain, Dizziness, Presyncope, Dyspnoea, Body temperature decreased, Tinnitus, Visual impairment, Nontherapeutic agent blood positive, Suspected product quality issue,
GADOBUTROL, THYROID, PORCINE,
91
26546113
EU
 30 1
Maculopathy, Disruption of the photoreceptor inner segment-outer segment, Visual field defect, Retinal disorder, Visual impairment,
SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL POWDER,,
92
26546441
GB
 79 2
Clumsiness, Ear pain, Headache, Tinnitus, Visual impairment,
ESTRADIOL/NORETHINDRONE ACETATE, FAMOTIDINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM,
93
26554314
54 2
Blindness, Visual impairment, Halo vision,
AMBRISENTAN,
94
26554712
1
Visual impairment, Colour vision tests abnormal, Optic neuritis, Colour blindness,
LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS,
95
26558212
62 2
Facial paresis, Visual impairment, Muscular weakness, Dyspnoea,
ONABOTULINUMTOXINA, ESOMEPRAZOLE MAGNESIUM,
96
26535878
US
 71
Visual impairment,
INSULIN LISPRO, INSULIN LISPRO,
97
26535914
US
 2
Gait inability, Speech disorder, Dyspnoea, Visual impairment, Hypoaesthesia, Tremor, Musculoskeletal disorder, Dissociation, Seizure, Botulism,
ONABOTULINUMTOXINA, ONABOTULINUMTOXINA,
98
26536076
US
 50 2
Visual impairment, Drug ineffective,
TIRZEPATIDE, TIRZEPATIDE,
99
26536511
US
 57 2
Visual impairment,
NATALIZUMAB,
100
26536569
US
 48 2
Visual impairment, Dyschezia, Rectal haemorrhage,
TIRZEPATIDE,

disclaimer

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.

terms

https://open.fda.gov/terms/

license

https://open.fda.gov/license/

last_updated

2026-04-28

Next page: 2 next page>>